Derek B. Mulvey, the Interim Chief Financial Officer (CFO) of Rivian Automotive, has filed a Form 3 with the SEC, detailing his ownership of 296,200 shares of the company's Class A Common Stock. This filing is significant as it reflects Mulvey's vested interests in Rivian, a major player in the electric vehicle industry, and underscores the importance of executive ownership in enhancing investor confidence.
Background
Rivian Automotive, Inc. is a publicly traded company specializing in the manufacturing of electric vehicles. The company is incorporated in Delaware and operates under the Central Index Key (CIK) 0001874178. Rivian is classified under the Standard Industrial Classification (SIC) code for Motor Vehicles & Passenger Car Bodies. The company has been actively filing with the SEC, with its most recent filing being the Form 3 submitted on October 30, 2026.
What the Filing Says
The Form 3 filing indicates that Derek B. Mulvey owns a total of 296,200 shares of Rivian's Class A Common Stock. According to the filing, this amount consists of:
(i) 73,057 shares resulting from previously vested Restricted Stock Units (RSUs), (ii) 1,798 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan, (iii) 2,490 shares purchased pursuant to the Issuer's Directed Share Program at the time of its Initial Public Offering, and (iv) 218,855 unvested RSUs.
Of the unvested RSUs, specific vesting schedules are outlined, indicating a structured approach to executive compensation.
Impact
This filing may influence various stakeholders, including investors and analysts, who closely monitor executive ownership as a sign of confidence in the company's future. Rivian's position in the electric vehicle market makes it a focal point for competition, particularly as the industry continues to evolve with new entrants and technological advancements.
What's Next
The filing does not say what happens next.
Read Next
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals
Paolini to Sell 96,000 Shares of Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals officer sells 47,540 shares
Moradi David files to sell 200,000 shares of AudioEye, Inc.
Arista Networks' Bechtolsheim Sells 267,892 Shares of Stock








